Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma
Titel:
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma
Auteur:
Cavo, Michele Pantani, Lucia Petrucci, Maria Teresa Patriarca, Francesca Zamagni, Elena Donnarumma, Daniela Crippa, Claudia Boccadoro, Mario Perrone, Giulia Falcone, Antonietta Nozzoli, Chiara Zambello, Renato Masini, Luciano Furlan, Anna Brioli, Annamaria Derudas, Daniele Ballanti, Stelvio Dessanti, Maria Laura De Stefano, Valerio Carella, Angelo Michele Marcatti, Magda Nozza, Andrea Ferrara, Felicetto Callea, Vincenzo Califano, Catello Pezzi, Annalisa Baraldi, Anna Grasso, Mariella Musto, Pellegrino Palumbo, Antonio